Pointe Scientific, Inc.
United StatesFDA applicant, unverified
Pointe Scientific, Inc. is a medical device manufacturer, with 74 devices listed in FDA 510(k) (FDA Class II and I) and 81 FDA recalls as of 21 Nov 2026.
- Devices
- 74
- FDA recalls
- 81
Registry facts
- Registries
- FDA 510(k) 74
- Device classes
- FDA Class II 53
- FDA Class I 21
- FDA recalls
- Identifiers
- DUNS 045623154
At a glance
Market reach
- United States
- FDA recalls
What Pointe Scientific, Inc. makes
Pointe Scientific, Inc. manufactures in vitro diagnostics (IVDs) for clinical chemistry and drug testing, including reagents, kits, and calibrators for measuring triglycerides, bilirubin, liver enzymes (ALT, AST), creatinine, calcium, phosphate, uric acid, lactate dehydrogenase, and methadone metabolites. Their products also cover drug-of-abuse testing, such as cannabinoids (THC) and calibrators for spectrophotometric assays.
The company’s portfolio includes Class I and Class II devices, all listed in the FDA’s Unique Device Identifier (UDI) database.
Catalogue
Search and filter all 74 devicesShowing 1-50 of 74
Company details
- DUNS number
- 045623154
- Phone
- 800-445-9853
FDA recalls
2015
- 19 May 2015 Z-2487-2015 Class II Terminated A reduction in the reconstituted stability has been identified.
Clinicians may notice a drop in recovery of the control after reconstitution, which could result in an out of specification result prior to the current reconstitution claim of 7 days. For this reason we suggest discontinuing use of the control set.
Full distribution text
- 13 Mar 2015 Z-2764-2015 Class III Terminated Crystals may be observed in the R1 reagent. Crystals may be a result of the reagent being frozen during transport. The crystals do not impact product performance.
- 19 May 2015 Z-2487-2015 Class II Terminated A reduction in the reconstituted stability has been identified.
Clinicians may notice a drop in recovery of the control after reconstitution, which could result in an out of specification result prior to the current reconstitution claim of 7 days. For this reason we suggest discontinuing use of the control set.
2014
- 12 Dec 2014 Z-2773-2015 Class III Terminated Creatinine kit C7539-150 contains Creatinine reagent R1 that is labeled as Creatinine reagent R2 (30ml) and reagent R2 vial is labeled as R1 (120ml). With manual procedure, no result will be reported as the control will be out of specifications.
2009
- 1 Dec 2009 Z-0912-2010 Unclassified (pre-2012) Terminated A process deviation occurred during the production of the R1 component which may affect its performance.
Full distribution text
- 1 Dec 2009 Z-0913-2010 Unclassified (pre-2012) Terminated A process deviation occurred during the production of the R1 component which may affect its performance.
Full distribution text
- 1 Dec 2009 Z-1035-2010 Unclassified (pre-2012) Terminated An additional 10% picric acid was added to the R2 component during production.
Full distribution text
- 1 Dec 2009 Z-1036-2010 Unclassified (pre-2012) Terminated An additional 10% picric acid was added to the R2 component during production.
Full distribution text
- 16 Nov 2009 Z-0899-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0900-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0901-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 1 Dec 2009 Z-0912-2010 Unclassified (pre-2012) Terminated A process deviation occurred during the production of the R1 component which may affect its performance.
Show the 25 most recent of 81 recalls
2009
- 16 Nov 2009 Z-0902-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0903-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0904-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0905-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 16 Nov 2009 Z-0906-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Full distribution text
- 10 Nov 2009 Z-0859-2010 Unclassified (pre-2012) Terminated The firm initiated the recall due to the presence of visible contamination of the product.
Full distribution text
- 10 Nov 2009 Z-0860-2010 Unclassified (pre-2012) Terminated The firm initiated the recall due to the presence of visible contamination of the product.
Full distribution text
- 10 Nov 2009 Z-1041-2010 Unclassified (pre-2012) Terminated Non-compliance with the Good Manufacturing Practice regulations, as the manufacturing process for this product had not been validated.
- 10 Nov 2009 Z-1042-2010 Unclassified (pre-2012) Terminated Non-compliance with the Good Manufacturing Practice regulations, as the manufacturing process for this product had not been validated.
- 10 Nov 2009 Z-1043-2010 Unclassified (pre-2012) Terminated Non-compliance with the Good Manufacturing Practice regulations, as the manufacturing process for this product had not been validated.
- 19 Oct 2009 Z-0104-2010 Unclassified (pre-2012) Terminated There is a loss of linearity. The product fails to maintain linearity specification of 500 mg/dL.
- 29 Jul 2009 Z-1014-2010 Unclassified (pre-2012) Terminated R2 reagent component may fail because it may contain R1 reagent. The reagent was rendered inoperative and would not pass the required quality control (calibration and quality control testing) before beginning running the bilirubin assay.
- 2 Feb 2009 Z-1202-2009 Unclassified (pre-2012) Terminated The product performance fails due to precipitation of the R2 component.
- 29 Jan 2009 Z-1200-2009 Unclassified (pre-2012) Terminated The R1 reagent has microbial contamination.
Full distribution text
- 29 Jan 2009 Z-1201-2009 Unclassified (pre-2012) Terminated The R1 reagent has microbial contamination.
Full distribution text
- 16 Nov 2009 Z-0902-2010 Unclassified (pre-2012) Terminated Turbidity formation could occur, resulting in invalid test results being reported out.
Frequently asked questions
How many devices does POINTE SCIENTIFIC, INC. have in the registry?
The registry currently lists 74 devices for POINTE SCIENTIFIC, INC.. Devices recorded under merged duplicate company entries are counted once.
Which registries list POINTE SCIENTIFIC, INC.'s devices?
Among its 50 most recently registered devices, POINTE SCIENTIFIC, INC. has devices listed in FDA 510(k) (50 devices).
What risk classes do POINTE SCIENTIFIC, INC.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for POINTE SCIENTIFIC, INC.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for POINTE SCIENTIFIC, INC.?
FDA recall records list 81 recalls initiated by POINTE SCIENTIFIC, INC., the most recent initiated on 19 May 2015. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from POINTE SCIENTIFIC, INC. in the registry?
The most recently registered devices listed for POINTE SCIENTIFIC, INC. include LIQUID GGT (GAMMA GLUTAMYL TRANSFERASE) REAGENT SET, LIQUID GLUCOSE (OXIDASE) REAGENT SET, LIQUID AMYLASE REAGENT SET and DIRECT BILIRUBIN.